Compare Cassava Sciences Inc (FLNA) vs YieldMax MSTR Option Income Strategy ETF (MSTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs YieldMax MSTR Option Income Strategy ETF — how do they compare? Cassava Sciences Inc trades at $1.06 (market cap $53.14M), while YieldMax MSTR Option Income Strategy ETF trades at $12.78. Which is the better fit depends on your goals.
| FLNA | MSTY | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $4.64 | $114.30 |
52-Week Low | $1.09 | $11.55 |
Enterprise Value | -$33.43M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
MSTY trades at $12.75, down 3.41% today amid bearish technical signals. The ETF shows consistent weekly dividend distributions but faces significant price erosion, with technical indicators showing bearish moving averages and neutral oscillators. Recent news highlights concerns about uncapped losses despite high distributions, with the fund experiencing substantial NAV decline over the past year.
The outlook remains challenging as MSTY's high-yield strategy comes with structural risks including return of capital distributions and capped upside potential. Investors face the dual risk of NAV erosion and dependency on Bitcoin-related volatility, requiring careful assessment of total return potential versus income generation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About YieldMax MSTR Option Income Strategy ETF
MSTY is an actively managed ETF that pursues a synthetic covered call strategy on MicroStrategy Incorporated (MSTR) stock. The fund primarily sells call options on MSTR and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the volatile, Bitcoin-correlated growth potential of MSTR while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on MSTY →
